HSP90AB1 and hepatocellular carcinoma: Meng and colleagues evaluated angiogenesis in hepatocellular carcinoma following HSP90α or HSP90β knockdown and observed that HSP90β inhibitors inhibited VEGFR-mediated angiogenesis [50,51].